To convert the meeting times to your local time Click Here
Session Description: This interactive and exciting session will feature international thought leaders in cervical cancer to discuss challenges in the current standard of care, from prevention to second-line and greater chemotherapy. The first half of the session will discuss the current status of HPV vaccination, the gap between cervical cancer incidence and eradication, and clinical dilemmas in stage allocation and surgery/radiation overlap for optimal patient management in low volume disease. The second half will discuss ongoing and resulted clinical trial that are ushering in a new era of immunotherapy for locally advanced and metastatic/recurrent cervical cancer.
This session is supported by Industry.